{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:41Z","timestamp":1786988141726,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010454"],"award-info":[{"award-number":["2023A1515010454"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177782","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T19:28:35Z","timestamp":1748374115000},"page":"177782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Teneligliptin, a DPP4 inhibitor protects dopaminergic neurons in PD models via inhibiting of oxidative stress and ferroptosis"],"prefix":"10.1016","volume":"1002","author":[{"given":"Linting","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakai","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirou","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0377-3178","authenticated-orcid":false,"given":"Wenya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177782_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.09.015","article-title":"\u03b1-Syn overexpression, NRF2 suppression, and enhanced ferroptosis create a vicious cycle of neuronal loss in Parkinson's disease","volume":"192","author":"A","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.177782_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12035-013-8554-z","article-title":"Neurodegeneration in Parkinson's disease: interactions of oxidative stress, tryptophan catabolites and depression with mitochondria and sirtuins","volume":"49","author":"Anderson","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177782_bib3","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1038\/s41418-020-0542-z","article-title":"Alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation","volume":"27","author":"Angelova","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2025.177782_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22095010","article-title":"Glutathione in the brain","volume":"22","author":"Aoyama","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177782_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10787-017-0331-6","article-title":"Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease","volume":"25","author":"Badawi","year":"2017","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2025.177782_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s12640-019-9998-3","article-title":"Sitagliptin and liraglutide modulate L-dopa effect and attenuate dyskinetic movements in rotenone-lesioned rats","volume":"35","author":"Badawi","year":"2019","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2025.177782_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107439","article-title":"Type 2 diabetes mellitus and neurodegenerative disorders: the mitochondrial connection","volume":"209","author":"Baduini","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.177782_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.trsl.2017.11.007","article-title":"Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma","volume":"193","author":"Bartolini","year":"2018","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejphar.2025.177782_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.177782_bib10","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1093\/brain\/awab191","article-title":"The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease","volume":"144","author":"Biondetti","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2025.177782_bib11","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s12035-019-01832-1","article-title":"The role of xenobiotics and trace metals in Parkinson's disease","volume":"57","author":"Bj\u00f8rklund","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177782_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/jnc.13581","article-title":"Dissecting the role of redox signaling in neuronal development","volume":"137","author":"B\u00f3rquez","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2025.177782_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.05.034","article-title":"Structural basis of Keap1 interactions with Nrf2","volume":"88","author":"Canning","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.177782_bib14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41420-022-01063-9","article-title":"Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity","volume":"8","author":"Cao","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2025.177782_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","article-title":"Nrf2 at the heart of oxidative stress and cardiac protection","volume":"50","author":"Chen","year":"2018","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.ejphar.2025.177782_bib16","article-title":"Glutathione peroxidase 4 (Gpx4) and ferroptosis: what's so special about it?","volume":"2","author":"Conrad","year":"2015","journal-title":"Mol Cell Oncol"},{"key":"10.1016\/j.ejphar.2025.177782_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101263","article-title":"Oxidative stress and regulated cell death in Parkinson's disease","volume":"67","author":"Dion\u00edsio","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177782_bib18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/bc.bc_21_21","article-title":"Exendin-4 for Parkinson's disease","volume":"7","author":"Esparza-Salazar","year":"2021","journal-title":"Brain Circ"},{"key":"10.1016\/j.ejphar.2025.177782_bib19","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.177782_bib20","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3389\/fnins.2019.01112","article-title":"Glucagon-like Peptide-1: a focus on neurodegenerative diseases","volume":"13","author":"Grieco","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177782_bib21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.freeradbiomed.2024.07.018","article-title":"Acteoside alleviates lipid peroxidation by enhancing Nrf2-mediated mitophagy to inhibit ferroptosis for neuroprotection in Parkinson's disease","volume":"223","author":"Han","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.177782_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177782_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2025.177782_bib24","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.18632\/aging.206074","article-title":"Association between dipeptidyl peptidase-4 inhibitor use and risk of Parkinson's disease among patients with diabetes mellitus: a retrospective cohort study","volume":"16","author":"Huang","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejphar.2025.177782_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11113094","article-title":"On the role of iron in idiopathic Parkinson's disease","volume":"11","author":"Huenchuguala","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2025.177782_bib26","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3748\/wjg.v19.i15.2298","article-title":"Dipeptidyl peptidase-4: a key player in chronic liver disease","volume":"19","author":"Itou","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177782_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14802\/jmd.25008","article-title":"Drug repositioning and repurposing for disease-modifying effects in Parkinson\u2019s disease","volume":"18","author":"Jeong","year":"2025","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.ejphar.2025.177782_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107370","article-title":"Targeting ferroptosis as a potential prevention and treatment strategy for aging-related diseases","volume":"208","author":"Jiao","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.177782_bib29","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.2174\/1570159X20666220222150811","article-title":"An update on nondopaminergic treatments for motor and non-motor symptoms of Parkinson's disease","volume":"21","author":"Jing","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2025.177782_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.physbeh.2018.01.028","article-title":"Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced parkinsonism: role of toll-like receptor 4, TGF-\u03b21, NF-\u03baB and glucagon-like peptide 1","volume":"188","author":"Kabel","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2025.177782_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.redox.2012.10.001","article-title":"The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer","volume":"1","author":"Kansanen","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2025.177782_bib32","article-title":"Targeting molecular mediators of ferroptosis and oxidative stress for neurological disorders","author":"Li","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2025.177782_bib33","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.1074\/jbc.272.26.16498","article-title":"Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products","volume":"272","author":"Li","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177782_bib34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1186\/s12967-024-05881-6","article-title":"Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.177782_bib35","article-title":"Bioinformatics analysis identifies potential ferroptosis key genes in the pathogenesis of intracerebral hemorrhage","volume":"15","author":"Liu","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177782_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16152720","article-title":"The role of DPP-4 inhibitors in the treatment algorithm of type 2 diabetes mellitus: when to select, what to expect","volume":"16","author":"Makrilakis","year":"2019","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.ejphar.2025.177782_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.177782_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110210","article-title":"Ferroptosis and cognitive impairment: unraveling the link and potential therapeutic targets","volume":"263","author":"Naderi","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.177782_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/exnr.2002.8056","article-title":"1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum","volume":"179","author":"Nakai","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177782_bib40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuropharm.2014.10.007","article-title":"Saxagliptin: a novel antiparkinsonian approach","volume":"89","author":"Nassar","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2025.177782_bib41","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177782_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101979","article-title":"Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease","volume":"89","author":"Nowell","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177782_bib43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.acra.2015.07.014","article-title":"Diabetes, gray matter loss, and cognition in the setting of parkinson disease","volume":"23","author":"Petrou","year":"2016","journal-title":"Acad. Radiol."},{"key":"10.1016\/j.ejphar.2025.177782_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2025.177782_bib45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12020-016-1052-0","article-title":"The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory","volume":"56","author":"Pujadas","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ejphar.2025.177782_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1742-2094-9-44","article-title":"Dipeptidyl peptidase IV, aminopeptidase N and DPIV\/APN-like proteases in cerebral ischemia","volume":"9","author":"R\u00f6hnert","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2025.177782_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.freeradbiomed.2016.12.046","article-title":"Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal","volume":"111","author":"Romano","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.177782_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117862","article-title":"An update on drug repurposing in Parkinson's disease: preclinical and clinical considerations","volume":"183","author":"Salvad\u00e8","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177782_bib49","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.222836","article-title":"p62\/SQSTM1 - steering the cell through health and disease","volume":"131","author":"S\u00e1nchez-Mart\u00edn","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2025.177782_bib50","article-title":"Neuroprotection against aminochrome neurotoxicity: glutathione transferase M2-2 and DT-Diaphorase","volume":"11","author":"Segura-Aguilar","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.ejphar.2025.177782_bib51","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177782_bib52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2025.177782_bib53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177782_bib54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41420-024-02037-9","article-title":"Ferroptosis: a double-edged sword","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2025.177782_bib55","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejphar.2016.08.011","article-title":"Protective role of 6-Hydroxy-1-H-Indazole in an MPTP-induced mouse model of Parkinson's disease","volume":"791","author":"Xiao-Feng","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177782_bib56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2025.177782_bib57","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","article-title":"The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity","volume":"20","author":"Xie","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.177782_bib58","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0891-5849(02)01360-6","article-title":"The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults","volume":"34","author":"Yant","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2025.177782_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104611","article-title":"Neuromodulatory effects of anti-diabetes medications: a mechanistic review","volume":"152","author":"Yaribeygi","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.177782_bib60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of parkinson's syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejphar.2025.177782_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101207","article-title":"Novel target for treating Alzheimer's diseases: crosstalk between the Nrf2 pathway and autophagy","volume":"65","author":"Zhang","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177782_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177782_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2022.136579","article-title":"Vildagliptin improves neurological function by inhibiting apoptosis and ferroptosis following intracerebral hemorrhage in mice","volume":"776","author":"Zhang","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177782_bib64","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopha.2018.10.016","article-title":"Teneligliptin protects against hypoxia\/reoxygenation-induced endothelial cell injury","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.177782_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1282584","article-title":"Efficacy and safety of teneligliptin in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Endocrinol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925005369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:22:12Z","timestamp":1778876532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925005369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":65,"alternative-id":["S0014299925005369"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177782","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Teneligliptin, a DPP4 inhibitor protects dopaminergic neurons in PD models via inhibiting of oxidative stress and ferroptosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177782","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177782"}}